These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 16766403)

  • 1. Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient.
    Baatz H; Mirshahi A; Puchta J; Gümbel H; Hattenbach LO
    Ocul Immunol Inflamm; 2006 Jun; 14(3):185-7. PubMed ID: 16766403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients.
    Pearson PA; Piracha AR; Sen HA; Jaffe GJ
    Ophthalmology; 1999 Jan; 106(1):148-53. PubMed ID: 9917796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
    Gormley PD; Pavesio CE; Minnasian D; Lightman S
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1171-5. PubMed ID: 9620076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of toxoplasmosis retinochoroiditis with atovaquone in an AIDS patient].
    Schimkat M; Althaus C; Armbrecht C; Jablonowski H; Sundmacher R
    Klin Monbl Augenheilkd; 1995 Mar; 206(3):173-7. PubMed ID: 7616727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?
    Winterhalter S; Severing K; Stammen J; Maier AK; Godehardt E; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2010 Aug; 248(8):1187-92. PubMed ID: 20437247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of toxoplasmosis retinochoroiditis with atovaquone in an immunocompetent patient].
    Hudde T; Althaus C; Schimkat M; Sundmacher R
    Klin Monbl Augenheilkd; 1996 Oct; 209(4):232-6. PubMed ID: 9044964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?
    Peacock JE; Greven CM; Cruz JM; Hurd DD
    Bone Marrow Transplant; 1995 Jun; 15(6):983-7. PubMed ID: 7581102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis.
    Silveira C; Vallochi AL; Rodrigues da Silva U; Muccioli C; Holland GN; Nussenblatt RB; Belfort R; Rizzo LV
    Br J Ophthalmol; 2011 Mar; 95(3):396-400. PubMed ID: 20601663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid syndrome following toxoplasma retinochoroiditis.
    Tavakoli M; Roghaee S; Soheilian R; Soheilian M
    Ocul Immunol Inflamm; 2011 Oct; 19(5):311-3. PubMed ID: 21864013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxoplasmic central chorioretinitis].
    Macarie S; Hulpuş A; Rusu I
    Oftalmologia; 2010; 54(2):71-4. PubMed ID: 20827914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review.
    Stanford MR; See SE; Jones LV; Gilbert RE
    Ophthalmology; 2003 May; 110(5):926-31; quiz 931-2. PubMed ID: 12750091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
    Katlama C; Mouthon B; Gourdon D; Lapierre D; Rousseau F
    AIDS; 1996 Sep; 10(10):1107-12. PubMed ID: 8874627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branch retinal arterial occlusion associated with toxoplasmic chorioretinitis.
    Küçükerdönmez C; Yilmaz G; Akova YA
    Ocul Immunol Inflamm; 2004 Sep; 12(3):227-31. PubMed ID: 15385198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual toxoplasmic chorioretinitis in advanced age: a diagnostic problem.
    Mataftsi A; Fragkou A; Vezyri E; Topouzis F; Diza E; Dimitrakos SA
    Semin Ophthalmol; 2011 Jan; 26(1):4-6. PubMed ID: 21275597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical, severe toxoplasmic retinochoroiditis in elderly patients.
    Johnson MW; Greven GM; Jaffe GJ; Sudhalkar H; Vine AK
    Ophthalmology; 1997 Jan; 104(1):48-57. PubMed ID: 9022104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil.
    Silveira C; Muccioli C; Holland GN; Jones JL; Yu F; de Paulo A; Belfort R
    Am J Ophthalmol; 2015 Jun; 159(6):1013-1021.e3. PubMed ID: 25743340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New trends in ocular toxoplasmosis--the review].
    Borkowski PK
    Przegl Epidemiol; 2001; 55(4):483-93. PubMed ID: 11921736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Observations of children with chorioretinitis in congenital toxoplasmosis].
    Jankowska H; Szczepańska-Putz M
    Pol Tyg Lek; 1992 Mar 2-9; 47(9-10):232-3. PubMed ID: 1437826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of bilateral acquired toxoplasmic retinochoroiditis during erlotinib therapy.
    Rao V; Schneider E; Proia AD; Fekrat S
    JAMA Ophthalmol; 2014 Sep; 132(9):1150-2. PubMed ID: 24993473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.